COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
Quantum Dot BiosensorsAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Kimberly Cole. A novel sensing approach for the detection of analytes based on the photonic properties of Quantum Dots (QD) will be described with particular reference to medical applications. Photoluminescence (PL) from the QD nanocrystal lattice is contained and stabilised by capping agents, which can be designed to react to microenvironmental molecules thus conferring a quantifiable photo-physical effect. The functional agent of choice is the biomolecule Glutathione (GSH) due to its reducing potential and metal-ion complexation abilities. In addition, the relatively simple and facile synthesis methodology delivers controllable size-dependant QD architectures with tunnable emissions (480nm-410nm) offering multiplexing potential. The performance of a glucose sensing platform will be the model for the proof-of-concept. This talk is part of the Thin Film Magnetic Talks series. This talk is included in these lists:Note that ex-directory lists are not shown. |
Other listsTesting & Verification For Computational Science Economics talks Cambridge ImmunologyOther talksStereodivergent Catalysis, Strategies and Tactics Towards Secondary Metabolites as enabling tools for the Study of Natural Products Biology Imaging surfaces with atoms Language Adaptation experiments: Cross-lingual embeddings for related languages Architecture and the English economy, 1200-1500: a new history of the parish church over the longue durée Statistical Learning Theory Research frontiers and new therapeutic strategies in pancreatic cancer Towards bulk extension of near-horizon geometries 'Walking through Language – Building Memory Palaces in Virtual Reality' Single Cell Seminars (October) Graded linearisations for linear algebraic group actions Protein Folding, Evolution and Interactions Symposium Childhood adversity and chronic disease: risks, mechanisms and resilience |